TY - JOUR
T1 - Amino Acid Functionalized Inorganic Nanoparticles as Cutting-Edge Therapeutic and Diagnostic Agents
AU - Chakraborty, Amlan
AU - Boer, Jennifer C.
AU - Selomulya, Cordelia
AU - Plebanski, Magdalena
N1 - Funding Information:
Magdalena Plebanski is an NHMRC Senior Research Fellow and Cordelia Selomulya an ARC Future Research Fellow. This project is supported by the Australian Research Council (ARC) under the Discovery program (DP150101058). Mr. Amlan Chakraborty is supported by a co-funded Monash Graduate Scholarship.
Publisher Copyright:
© 2017 American Chemical Society.
PY - 2018/3/21
Y1 - 2018/3/21
N2 - The field of medical diagnostics and therapeutics is being revolutionized by nanotechnology, from targeted drug delivery to cancer immunotherapy. Inorganic nanoparticles are widely used, albeit problems with agglutination, cytotoxicity, free radical generation, and instability in some biological environments limits their utility. Conjugation of biomolecules such as peptides to the surface of nanoparticles can mitigate such problems, as well as confer specialized theranostic (therapeutic and/or diagnostic) properties, useful across biomedical applications such as vaccines, drug delivery, and in vivo imaging. Coating with amino acids, rather than peptides, offers further a highly cost-effective approach (due to their ease of purification and availability), but is currently an underutilized way to decrease toxicity and enhance stability. Amino acid molecules are small (<200 Da) and have both positive and negative charge groups (zwitterionic) facilitating charge-specific molecule binding. Additionally, amino acids exert by themselves some useful biological functions, with antibacterial and viability enhancing properties (for eukaryotic cells). Overall particle size, nanoparticle core, and the specific amino acid used to functionalize their surface influence their biodistribution, and their effects on host immunity. In this review, we provide for the first time an overview of this emerging field, and identify gaps in knowledge for future research.
AB - The field of medical diagnostics and therapeutics is being revolutionized by nanotechnology, from targeted drug delivery to cancer immunotherapy. Inorganic nanoparticles are widely used, albeit problems with agglutination, cytotoxicity, free radical generation, and instability in some biological environments limits their utility. Conjugation of biomolecules such as peptides to the surface of nanoparticles can mitigate such problems, as well as confer specialized theranostic (therapeutic and/or diagnostic) properties, useful across biomedical applications such as vaccines, drug delivery, and in vivo imaging. Coating with amino acids, rather than peptides, offers further a highly cost-effective approach (due to their ease of purification and availability), but is currently an underutilized way to decrease toxicity and enhance stability. Amino acid molecules are small (<200 Da) and have both positive and negative charge groups (zwitterionic) facilitating charge-specific molecule binding. Additionally, amino acids exert by themselves some useful biological functions, with antibacterial and viability enhancing properties (for eukaryotic cells). Overall particle size, nanoparticle core, and the specific amino acid used to functionalize their surface influence their biodistribution, and their effects on host immunity. In this review, we provide for the first time an overview of this emerging field, and identify gaps in knowledge for future research.
UR - http://www.scopus.com/inward/record.url?scp=85044231052&partnerID=8YFLogxK
U2 - 10.1021/acs.bioconjchem.7b00455
DO - 10.1021/acs.bioconjchem.7b00455
M3 - Review article
C2 - 28876902
AN - SCOPUS:85044231052
SN - 1043-1802
VL - 29
SP - 657
EP - 671
JO - Bioconjugate Chemistry
JF - Bioconjugate Chemistry
IS - 3
ER -